Oxaliplatin (OXA) is the third-generation platinum anti-tumor drug after cisplatin and carboplatin. Oxaliplatin was jointly developed by Sanofi and Debiopharm for the first-line treatment of metastatic colon cancer and the adjuvant treatment of stage III colon cancer after complete resection of the primary tumor. It was approved to enter the Chinese market in 1999. By the end of 2020, there are nearly 20 manufacturers in China's Oxaliplatin market of which Sanofi-Aventis France has the largest market share.
According to CRI's market research, the sales value of Oxaliplatin in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the COVID-19 epidemic on the hospital's overall diagnosis and treatment services, the sales value of Oxaliplatin in the Chinese market decreased to CNY1.165 billion in 2020. The CAGR of Oxaliplatin's sales value in the Chinese market from 2016 to 2020 was 4.29%.
CRI expects that Oxaliplatin sales will have a restorative growth in 2021-2025 as the alleviation of the COVID-19 epidemic. In 2020, the number of new colon cancer cases in China was 550,000, with an increase of 46.28% from 376,000 in 2018. Therefore, Oxaliplatin sales will increase from 2016 to 2020 with the increase in the number of colon cancer patients.
Topics Covered:
-The impact of COVID-19 on China's Oxaliplatin market
- Sales value of China's Oxaliplatin 2016-2020
- Competitive landscape of China's Oxaliplatin market
- Prices of Oxaliplatin in China
- Prices of Oxaliplatin in China by regions and manufacturers
- Analysis of factors affecting the development of China's Oxaliplatin market
- Prospect of China's Oxaliplatin market from 2021 to 2025
Companies Mentioned
Sanofi-Aventis France,Jiangsu Hengrui Medicine Co., Ltd.,Shenzhen Neptunus Pharmaceutical Co.,Ltd.,Cisen Pharmaceutical Co., Ltd.,Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd.
Investigation Report on China's Oxaliplatin Market 2021-2025
Table of Contents
1 Relevant Concepts of Oxaliplatin
1.1 Indications for Oxaliplatin
1.2 Development of Oxaliplatin in China
1.3 Governmental Approval of Oxaliplatin in China
1.4 The Impact of COVID-19 on Oxaliplatin Sales in China
2 Sales of Oxaliplatin in China, 2016-2020
2.1 Sales Value of Oxaliplatin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Oxaliplatin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Oxaliplatin by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Analysis of Other Dosage Form
3 Analysis of Major Oxaliplatin Manufacturers in China in 2020
3.1 Analysis of Market Share of Major Oxaliplatin Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Sanofi-Aventis France
3.2.1 Enterprise Profile
3.2.2 Sales of ELOXATIN (Sanofi-Aventis France's Oxaliplatin) in China
3.3 Jiangsu Hengrui Medicine Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Aiheng (Jiangsu Hengrui Medicine Co., Ltd.'s Oxaliplatin) in China
3.4 Shenzhen Neptunus Pharmaceutical Co.,Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Aikebokang (Shenzhen Neptunus Pharmaceutical Co.,Ltd.'s Oxaliplatin) in China
3.5 Cisen Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Chenya (Cisen Pharmaceutical Co., Ltd.'s Oxaliplatin) in China
3.6 Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Jialetongtai (Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd.'s Oxaliplatin) in China
4 Prices of Oxaliplatin for Different Manufacturers in China, 2020-2021
4.1 Sanofi-Aventis France (ELOXATIN)
4.2 Jiangsu Hengrui Medicine Co., Ltd. (Aiheng)
4.3 Shenzhen Neptunus Pharmaceutical Co., Ltd. (Aikebokang)
4.4 Cisen Pharmaceutical Co., Ltd. (Chenya)
4.5 Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd. (Jialetongtai)
5 Prospect of Chinese Oxaliplatin Market, 2021-2025
5.1 Influential Factors of Chinese Oxaliplatin Market Development
5.1.1 The Impact of COVID-19 on Chinese Oxaliplatin Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Oxaliplatin Injection Registration in China
Chart Sales Value of Oxaliplatin Injection over the World
Chart Sales Value of Oxaliplatin Injection in China, 2016-2020
Chart Sales Value of Oxaliplatin Injection in China by Region, 2016-2020
Chart Sales Volume of Oxaliplatin Injection in China, 2016-2020
Chart Sales Volume of Oxaliplatin Injection in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Oxaliplatin Injection Manufacturers in China, 2016-2020
Chart Sales Value and Volume of ELOXATIN in China, 2016-2020
Chart Sales Value and Volume of Aiheng in China, 2016-2020
Chart Sales Value and Volume of Aikebokang in China, 2016-2020
Chart Sales Value and Volume of Chenya in China, 2016-2020
Chart Sales Value and Volume of Jialetongtai in China, 2016-2020
Chart Referential Prices of ELOXATIN in China by Region, 2020-2021
Chart Referential Prices of Aiheng in China by Region, 2020-2021
Chart Referential Prices of Aikebokang in China by Region, 2020-2021
Chart Referential Prices of Chenya in China by Region, 2020-2021
Chart Referential Prices of Jialetongtai in China by Region, 2020-2021
Chart Forecast on Sales Value of Oxaliplatin Injection in China, 2021-2025
Chart Forecast on Sales Volume of Oxaliplatin Injection in China, 2021-2025
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
